Systemic treatment for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Manushi, Arain, Abeer, Jin, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160617/
https://www.ncbi.nlm.nih.gov/pubmed/30276361
http://dx.doi.org/10.1016/j.cdtm.2018.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160617/
https://www.ncbi.nlm.nih.gov/pubmed/30276361
http://dx.doi.org/10.1016/j.cdtm.2018.08.003

Ejemplares similares